Nupafant, a PAF-antagonist prototype for suppression of ventricular fibrillation without liability for QT prolongation?
about
Ability to induce atrial fibrillation in the peri-operative period is associated with phosphorylation-dependent inhibition of TWIK protein-related acid-sensitive potassium channel 1 (TASK-1)Contractile function assessment by intraventricular balloon alters the ability of regional ischaemia to evoke ventricular fibrillationMolecular docking study on platelet-activating factor antagonistic activity of bioactive compounds isolated from Guttiferae and Ardisia species.
P2860
Nupafant, a PAF-antagonist prototype for suppression of ventricular fibrillation without liability for QT prolongation?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Nupafant, a PAF-antagonist pro ...... liability for QT prolongation?
@en
type
label
Nupafant, a PAF-antagonist pro ...... liability for QT prolongation?
@en
prefLabel
Nupafant, a PAF-antagonist pro ...... liability for QT prolongation?
@en
P2093
P2860
P356
P1476
Nupafant, a PAF-antagonist pro ...... liability for QT prolongation?
@en
P2093
P2860
P304
P356
10.1038/SJ.BJP.0706846
P407
P577
2006-08-21T00:00:00Z